← Back to Discover
Catalys Pacific, LLC
Period ended Sep 30, 2026 · Latest filing Oct 30, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $209,740,772
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Mineralys Therapeutics, Inc. · COM · 603170101 · shares: $196,001,887
- Phathom Pharmaceuticals, Inc. · COM · 71722W107 · shares: $13,738,885
Reported holdings
2 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | COM | 603170101 | — | 7,799,518 shares | $196,001,887 |
| Phathom Pharmaceuticals, Inc. | COM | 71722W107 | — | 1,882,039 shares | $13,738,885 |